-
Some call it a 'delay' -- we call it a 'strategic re-focusing'," [Theresa Oswald] said Friday.
"The Manitoba drug formulary needs to be updated on at least a bi-weekly basis as new generics are approved," [Kelvin Goertzen] said. "There is no downside for Manitoba patients or taxpayers to approving the generic drugs more quickly.
Tory health critic Kelvin Goertzen says 'not so fast'. He says the delay meant cheaper generic drugs weren't being prescribed to Manitobans as quickly as they were in other provinces. That delay has cost the province millions in potential savings.
-
Shoppers Drug Mart Inc. v. Ontario In 2010, regulations were made pursuant to each of the Ontario Drug Benefit Act (ODBA) and the Drug Interchangeabi...
-
...Docket: A-360-09. BETWEEN:. CANADIAN GENERIC PHARMACEUTICAL ASSOCIATION. Appellant and. ATTORNE... that subsection 30(3) of the Food and Drugs Act , R.S. 1985, c. F-25 (the Act) and section...
-
The Competition Bureau has released a new study of the generic
drug industry, Benefiting from Generic Drug Competition in
Canada: The Way Forward, th...
-
According to the association, the delay has already cost Manitoba more than $2 million in the last few months.
-
... services today to help cover the cost of drugs they will need later, without imposing problematic... years as large patents expire, more generic drugs come to market, the rate of introducing new ...
-
It is apparent now that supply for many generic products has become highly competitive," says the Competition Bureau report, marked "draft -- not for distribution.
"(But) the effects of the competition that takes place among manufacturers have traditionally not been reflected in (retail) prices for generic drugs... With price competition being focused on pharmacies, its effects are reflected in net pharmacy prices."
The chief way the generic producers compete for business is through rebates offered to pharmacies, often in the form of bulk payments covering a number of products. Those rebates can be as high as about 80 per cent of the wholesale, or "invoice," price, but average about 40 per cent, the report says.
-
John Le Carre in his book, The Constant Gardener, uses high drama, murder and mayhem to discredit Big Pharma, which he claims operates with "pathological secrecy, corruption and greed" and is a product of "unbridled capitalism." He purrs with praise for generic drugs: "They simply save the same lives that Big Pharma could save, but at a fraction of the cost.
On the fringes of rational thought are the fanatics who tell us we don't need drugs at all. According to them, most patients just think they have a problem. Your high cholesterol isn't a "real" illness. It's just something that can be cured with a good nutritious snack, followed by a detox and cleansing.
Except for AIDS. AIDS is a real illness. Garden veggies won't help here. But according to the bashers, it's still Big Pharma's f...
-
... vires of subsection 30(3) of the Food and Drugs Act, R.S.C. 1985, c. F-27 (the Act), and of the Da...
-
Almost from the beginning, one of the main objections to the construction of the plant in the St. Boniface Industrial Park was the prospect that trucks carrying millions of pigs to slaughter would be using the same roadways as other park tenants, including the makers of generic drugs. Such trucks are not the most hygienic -- the pigs they transport defecate in them. Some of that waste can slop onto roads and all of it creates odour. The prospect of trucks lining the streets of the park oozing waste and stink is, without doubt, objectionable.